0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Animal-derived Immune Globulin Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-13D12317
Home | Market Reports | Health| Pharmacy
Global Animal derived Immune Globulin Products Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Animal-derived Immune Globulin Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13D12317
Report
September 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal-derived Immune Globulin Products - Market Size

The global market for Animal-derived Immune Globulin Products was estimated to be worth US$ 1241 million in 2023 and is forecast to a readjusted size of US$ 1726.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Animal-derived Immune Globulin Products - Market

Animal-derived Immune Globulin Products - Market

Immune globulin (Ig) short-term protection against hepatitis A and measles
North American market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Animal-derived Immune Globulin Products was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal-derived Immune Globulin Products by region & country, by Type, and by Application.
The Animal-derived Immune Globulin Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin Products.
Market Segmentation

Scope of Animal-derived Immune Globulin Products - Market Report

Report Metric Details
Report Name Animal-derived Immune Globulin Products - Market
Forecasted market size in 2030 US$ 1726.3 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi, BTG Specialty Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Animal-derived Immune Globulin Products in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Animal-derived Immune Globulin Products - Market size in 2030?

Ans: The Animal-derived Immune Globulin Products - Market size in 2030 will be US$ 1726.3 million.

Who are the main players in the Animal-derived Immune Globulin Products - Market report?

Ans: The main players in the Animal-derived Immune Globulin Products - Market are Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi, BTG Specialty Pharmaceuticals

What are the Application segmentation covered in the Animal-derived Immune Globulin Products - Market report?

Ans: The Applications covered in the Animal-derived Immune Globulin Products - Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Animal-derived Immune Globulin Products - Market report?

Ans: The Types covered in the Animal-derived Immune Globulin Products - Market report are IVIg Liquid, IVIg Powder

Recommended Reports

Animal Vaccines

Immune Globulin

Animal Protein

1 Market Overview
1.1 Animal-derived Immune Globulin Products Product Introduction
1.2 Global Animal-derived Immune Globulin Products Market Size Forecast
1.2.1 Global Animal-derived Immune Globulin Products Sales Value (2019-2030)
1.2.2 Global Animal-derived Immune Globulin Products Sales Volume (2019-2030)
1.2.3 Global Animal-derived Immune Globulin Products Sales Price (2019-2030)
1.3 Animal-derived Immune Globulin Products Market Trends & Drivers
1.3.1 Animal-derived Immune Globulin Products Industry Trends
1.3.2 Animal-derived Immune Globulin Products Market Drivers & Opportunity
1.3.3 Animal-derived Immune Globulin Products Market Challenges
1.3.4 Animal-derived Immune Globulin Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal-derived Immune Globulin Products Players Revenue Ranking (2023)
2.2 Global Animal-derived Immune Globulin Products Revenue by Company (2019-2024)
2.3 Global Animal-derived Immune Globulin Products Players Sales Volume Ranking (2023)
2.4 Global Animal-derived Immune Globulin Products Sales Volume by Company Players (2019-2024)
2.5 Global Animal-derived Immune Globulin Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Animal-derived Immune Globulin Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Animal-derived Immune Globulin Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal-derived Immune Globulin Products
2.9 Animal-derived Immune Globulin Products Market Competitive Analysis
2.9.1 Animal-derived Immune Globulin Products Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal-derived Immune Globulin Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IVIg Liquid
3.1.2 IVIg Powder
3.2 Global Animal-derived Immune Globulin Products Sales Value by Type
3.2.1 Global Animal-derived Immune Globulin Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal-derived Immune Globulin Products Sales Value, by Type (2019-2030)
3.2.3 Global Animal-derived Immune Globulin Products Sales Value, by Type (%) (2019-2030)
3.3 Global Animal-derived Immune Globulin Products Sales Volume by Type
3.3.1 Global Animal-derived Immune Globulin Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Animal-derived Immune Globulin Products Sales Volume, by Type (2019-2030)
3.3.3 Global Animal-derived Immune Globulin Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Animal-derived Immune Globulin Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Animal-derived Immune Globulin Products Sales Value by Application
4.2.1 Global Animal-derived Immune Globulin Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal-derived Immune Globulin Products Sales Value, by Application (2019-2030)
4.2.3 Global Animal-derived Immune Globulin Products Sales Value, by Application (%) (2019-2030)
4.3 Global Animal-derived Immune Globulin Products Sales Volume by Application
4.3.1 Global Animal-derived Immune Globulin Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Animal-derived Immune Globulin Products Sales Volume, by Application (2019-2030)
4.3.3 Global Animal-derived Immune Globulin Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Animal-derived Immune Globulin Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Animal-derived Immune Globulin Products Sales Value by Region
5.1.1 Global Animal-derived Immune Globulin Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal-derived Immune Globulin Products Sales Value by Region (2019-2024)
5.1.3 Global Animal-derived Immune Globulin Products Sales Value by Region (2025-2030)
5.1.4 Global Animal-derived Immune Globulin Products Sales Value by Region (%), (2019-2030)
5.2 Global Animal-derived Immune Globulin Products Sales Volume by Region
5.2.1 Global Animal-derived Immune Globulin Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Animal-derived Immune Globulin Products Sales Volume by Region (2019-2024)
5.2.3 Global Animal-derived Immune Globulin Products Sales Volume by Region (2025-2030)
5.2.4 Global Animal-derived Immune Globulin Products Sales Volume by Region (%), (2019-2030)
5.3 Global Animal-derived Immune Globulin Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.4.2 North America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.5.2 Europe Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.6.2 Asia Pacific Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.7.2 South America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal-derived Immune Globulin Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value
6.2.1 Key Countries/Regions Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Animal-derived Immune Globulin Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.3.2 United States Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.4.2 Europe Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.5.2 China Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.6.2 Japan Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.7.2 South Korea Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.8.2 Southeast Asia Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal-derived Immune Globulin Products Sales Value, 2019-2030
6.9.2 India Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal-derived Immune Globulin Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Animal-derived Immune Globulin Products Product Offerings
7.1.5 Pfizer Recent Development
7.2 Rare Disease Therapeutics
7.2.1 Rare Disease Therapeutics Company Information
7.2.2 Rare Disease Therapeutics Introduction and Business Overview
7.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Offerings
7.2.5 Rare Disease Therapeutics Recent Development
7.3 Bioclon Institute
7.3.1 Bioclon Institute Company Information
7.3.2 Bioclon Institute Introduction and Business Overview
7.3.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bioclon Institute Animal-derived Immune Globulin Products Product Offerings
7.3.5 Bioclon Institute Recent Development
7.4 Merck & Co
7.4.1 Merck & Co Company Information
7.4.2 Merck & Co Introduction and Business Overview
7.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck & Co Animal-derived Immune Globulin Products Product Offerings
7.4.5 Merck & Co Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Animal-derived Immune Globulin Products Product Offerings
7.5.5 Sanofi Recent Development
7.6 BTG Specialty Pharmaceuticals
7.6.1 BTG Specialty Pharmaceuticals Company Information
7.6.2 BTG Specialty Pharmaceuticals Introduction and Business Overview
7.6.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Offerings
7.6.5 BTG Specialty Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Animal-derived Immune Globulin Products Industrial Chain
8.2 Animal-derived Immune Globulin Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal-derived Immune Globulin Products Sales Model
8.5.2 Sales Channel
8.5.3 Animal-derived Immune Globulin Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Animal-derived Immune Globulin Products Market Trends
    Table 2. Animal-derived Immune Globulin Products Market Drivers & Opportunity
    Table 3. Animal-derived Immune Globulin Products Market Challenges
    Table 4. Animal-derived Immune Globulin Products Market Restraints
    Table 5. Global Animal-derived Immune Globulin Products Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Animal-derived Immune Globulin Products Revenue Market Share by Company (2019-2024)
    Table 7. Global Animal-derived Immune Globulin Products Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Animal-derived Immune Globulin Products Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Animal-derived Immune Globulin Products Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Animal-derived Immune Globulin Products Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Animal-derived Immune Globulin Products Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Animal-derived Immune Globulin Products
    Table 13. Global Animal-derived Immune Globulin Products Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin Products as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Animal-derived Immune Globulin Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Animal-derived Immune Globulin Products Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Animal-derived Immune Globulin Products Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Animal-derived Immune Globulin Products Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Animal-derived Immune Globulin Products Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Animal-derived Immune Globulin Products Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Animal-derived Immune Globulin Products Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Animal-derived Immune Globulin Products Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Animal-derived Immune Globulin Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Animal-derived Immune Globulin Products Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Animal-derived Immune Globulin Products Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Animal-derived Immune Globulin Products Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Animal-derived Immune Globulin Products Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Animal-derived Immune Globulin Products Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Animal-derived Immune Globulin Products Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Animal-derived Immune Globulin Products Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Animal-derived Immune Globulin Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Animal-derived Immune Globulin Products Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Animal-derived Immune Globulin Products Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Animal-derived Immune Globulin Products Sales Value by Region (2019-2024) & (%)
    Table 44. Global Animal-derived Immune Globulin Products Sales Value by Region (2025-2030) & (%)
    Table 45. Global Animal-derived Immune Globulin Products Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Animal-derived Immune Globulin Products Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Animal-derived Immune Globulin Products Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Animal-derived Immune Globulin Products Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Animal-derived Immune Globulin Products Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Animal-derived Immune Globulin Products Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Animal-derived Immune Globulin Products Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Animal-derived Immune Globulin Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Animal-derived Immune Globulin Products Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Animal-derived Immune Globulin Products Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Animal-derived Immune Globulin Products Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Animal-derived Immune Globulin Products Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Animal-derived Immune Globulin Products Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Rare Disease Therapeutics Company Information
    Table 63. Rare Disease Therapeutics Introduction and Business Overview
    Table 64. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Offerings
    Table 66. Rare Disease Therapeutics Recent Development
    Table 67. Bioclon Institute Company Information
    Table 68. Bioclon Institute Introduction and Business Overview
    Table 69. Bioclon Institute Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Bioclon Institute Animal-derived Immune Globulin Products Product Offerings
    Table 71. Bioclon Institute Recent Development
    Table 72. Merck & Co Company Information
    Table 73. Merck & Co Introduction and Business Overview
    Table 74. Merck & Co Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Merck & Co Animal-derived Immune Globulin Products Product Offerings
    Table 76. Merck & Co Recent Development
    Table 77. Sanofi Company Information
    Table 78. Sanofi Introduction and Business Overview
    Table 79. Sanofi Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Sanofi Animal-derived Immune Globulin Products Product Offerings
    Table 81. Sanofi Recent Development
    Table 82. BTG Specialty Pharmaceuticals Company Information
    Table 83. BTG Specialty Pharmaceuticals Introduction and Business Overview
    Table 84. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Offerings
    Table 86. BTG Specialty Pharmaceuticals Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Animal-derived Immune Globulin Products Downstream Customers
    Table 90. Animal-derived Immune Globulin Products Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Animal-derived Immune Globulin Products Product Picture
    Figure 2. Global Animal-derived Immune Globulin Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Animal-derived Immune Globulin Products Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Animal-derived Immune Globulin Products Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Animal-derived Immune Globulin Products Report Years Considered
    Figure 7. Global Animal-derived Immune Globulin Products Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Animal-derived Immune Globulin Products Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Animal-derived Immune Globulin Products Revenue in 2023
    Figure 10. Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. IVIg Liquid Picture
    Figure 12. IVIg Powder Picture
    Figure 13. Global Animal-derived Immune Globulin Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Animal-derived Immune Globulin Products Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Animal-derived Immune Globulin Products Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Animal-derived Immune Globulin Products Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Animal-derived Immune Globulin Products Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Immunodeficiency
    Figure 19. Product Picture of Autoimmune Disease
    Figure 20. Product Picture of Acute Infection
    Figure 21. Global Animal-derived Immune Globulin Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Animal-derived Immune Globulin Products Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Animal-derived Immune Globulin Products Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Animal-derived Immune Globulin Products Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Animal-derived Immune Globulin Products Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Animal-derived Immune Globulin Products Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Animal-derived Immune Globulin Products Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Animal-derived Immune Globulin Products Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Animal-derived Immune Globulin Products Sales Volume (%), (2019-2030)
    Figure 38. United States Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Animal-derived Immune Globulin Products Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Animal-derived Immune Globulin Products Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Animal-derived Immune Globulin Products Sales Value by Application (%), 2023 VS 2030
    Figure 59. Animal-derived Immune Globulin Products Industrial Chain
    Figure 60. Animal-derived Immune Globulin Products Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart